Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 1
1989 3
1991 2
1993 1
1995 1
1996 1
1997 1
1999 1
2004 2
2005 1
2006 2
2007 2
2008 2
2009 2
2010 1
2011 2
2012 2
2016 1
2017 1
2023 1
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Can fenretinide protect women against ovarian cancer?
De Palo G, Veronesi U, Camerini T, Formelli F, Mascotti G, Boni C, Fosser V, Del Vecchio M, Campa T, Costa A, et al. De Palo G, et al. Among authors: campa t. J Natl Cancer Inst. 1995 Jan 18;87(2):146-7. doi: 10.1093/jnci/87.2.146. J Natl Cancer Inst. 1995. PMID: 7707390 Clinical Trial. No abstract available.
Tolerability of the synthetic retinoid Fenretinide (HPR).
Costa A, Malone W, Perloff M, Buranelli F, Campa T, Dossena G, Magni A, Pizzichetta M, Andreoli C, Del Vecchio M, et al. Costa A, et al. Among authors: campa t. Eur J Cancer Clin Oncol. 1989 May;25(5):805-8. doi: 10.1016/0277-5379(89)90124-7. Eur J Cancer Clin Oncol. 1989. PMID: 2525470 Clinical Trial.
Palliative sedation at the end of life at a tertiary cancer center.
Caraceni A, Zecca E, Martini C, Gorni G, Campa T, Brunelli C, De Conno F. Caraceni A, et al. Among authors: campa t. Support Care Cancer. 2012 Jun;20(6):1299-307. doi: 10.1007/s00520-011-1217-6. Epub 2011 Jul 16. Support Care Cancer. 2012. PMID: 21766162
Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.
Veronesi U, De Palo G, Marubini E, Costa A, Formelli F, Mariani L, Decensi A, Camerini T, Del Turco MR, Di Mauro MG, Muraca MG, Del Vecchio M, Pinto C, D'Aiuto G, Boni C, Campa T, Magni A, Miceli R, Perloff M, Malone WF, Sporn MB. Veronesi U, et al. Among authors: campa t. J Natl Cancer Inst. 1999 Nov 3;91(21):1847-56. doi: 10.1093/jnci/91.21.1847. J Natl Cancer Inst. 1999. PMID: 10547391 Clinical Trial.
Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrual.
De Palo G, Camerini T, Marubini E, Costa A, Formelli F, Del Vecchio M, Mariani L, Miceli R, Mascotti G, Magni A, Campa T, Di Mauro MG, Attili A, Maltoni C, Del Turco MR, Decensi A, D'Aiuto G, Veronesi U. De Palo G, et al. Among authors: campa t. Tumori. 1997 Nov-Dec;83(6):884-94. doi: 10.1177/030089169708300603. Tumori. 1997. PMID: 9526578 Clinical Trial.
Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS).
Mercadante S, Marchetti P, Cuomo A, Caraceni A, Mediati RD, Mammucari M, Natoli S, Lazzari M, Dauri M, Airoldi M, Azzarello G, Bandera M, Blasi L, Cartenì G, Chiurazzi B, Costanzo BVP, Degiovanni D, Fusco F, Guardamagna V, Iaffaioli V, Liguori S, Lorusso V, Mameli S, Mattioli R, Mazzei T, Melotti RM, Menardo V, Miotti D, Moroso S, De Santis S, Orsetti R, Papa A, Ricci S, Sabato AF, Scelzi E, Sofia M, Tonini G, Aielli F, Valle A; IOPS MS study group. Mercadante S, et al. Adv Ther. 2017 Jan;34(1):120-135. doi: 10.1007/s12325-016-0440-4. Epub 2016 Nov 21. Adv Ther. 2017. PMID: 27873235 Free PMC article.
30 results